5-Hydroxyindoleacetic acid (5-HIAA) and cortisol excretion as predictors of chemotherapy-induced emesis
1996

Cortisol and 5-HIAA as Predictors of Nausea and Vomiting in Chemotherapy

Sample size: 49 publication Evidence: moderate

Author Information

Author(s): A du Bois, W Vach, U Wechsel, R Holy, W Schaefer

Primary Institution: St Vincentius Hospitals, Karlsruhe, Germany; University of Freiburg, Germany

Hypothesis

The study aims to evaluate the relationship between pre-chemotherapy cortisol and 5-HIAA excretion and chemotherapy-induced emesis.

Conclusion

Low basal cortisol excretion may serve as a useful predictor for chemotherapy-induced emesis.

Supporting Evidence

  • Emesis was observed in 37% of all patients on days 1-3.
  • Lower cortisol excretion was significantly correlated with vomiting.
  • 5-HIAA showed a weak correlation with emesis on days 1-3.

Takeaway

This study found that lower levels of cortisol in urine before chemotherapy can help predict if a patient will feel sick and vomit after treatment.

Methodology

The study measured urinary excretion of cortisol and 5-HIAA in patients before chemotherapy and documented vomiting and nausea over a 3-day observation period.

Potential Biases

Potential bias due to the exclusion of patients with renal or endocrinological disorders.

Limitations

The study only included female patients and had a small sample size for some analyses.

Participant Demographics

All participants were female patients with gynaecological cancer, median age 54.5 years.

Statistical Information

P-Value

0.03

Confidence Interval

27-104 for cortisol; 126-238 for 5-HIAA

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication